Novel Oxygen-Dependent Degradable Immunotoxin Regulated by the Ubiquitin-Proteasome System Reduces Nonspecific

Min Wei1, Anxiang Chen1, Jian Zhang1

  • 1State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Molecular Pharmaceutics
|October 28, 2022
PubMed

Insights

Engineered immunotoxins fuse bacterial toxins with oxygen-sensing domains to target cancer cells. This approach reduces side effects by degrading the toxin in normal cells, offering a promising cancer therapy.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Bacterial toxins and immunotoxins are explored as antitumor agents.
  • Immunotoxins show potent tumor cell killing but cause nonspecific toxicity.
  • Hypoxia-inducible factor 1α (HIF-1α) indicates cancer cell hypoxia.

Purpose of the Study:

  • To engineer an oxygen-dependent degradable immunotoxin (DS-ODDD) for cancer therapy.
  • To reduce nonspecific toxicity of immunotoxins in normal cells.
  • To investigate the degradation mechanism and therapeutic potential of the engineered immunotoxin.

Main Methods:

  • Fusion of immunotoxin DAB389-4D5 scFv (DS) with HIF-1α's oxygen-dependent degradation domain (ODDD).
  • Construction and testing of the engineered fusion protein DSO-2 with a (G4S)3 linker.
  • Analysis of DSO-2 degradation via ubiquitin-proteasome pathway and its effect on apoptosis-related molecules.

Main Results:

  • DSO-2 demonstrated potent cancer cell killing under hypoxia.
  • DSO-2 exhibited significantly reduced nonspecific toxicity to normal cells under normoxic conditions.
  • DSO-2 degradation is regulated by an oxygen-sensitive ubiquitin-proteasome pathway, decreasing apoptosis in normal cells.

Conclusions:

  • The engineered oxygen-sensing immunotoxin DSO-2 is a potential therapeutic agent for cancer treatment.
  • Targeted degradation of immunotoxins based on cellular oxygen levels can minimize side effects.
  • This strategy offers a novel approach to enhance the safety and efficacy of immunotoxin-based cancer therapies.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.2K